Free Trial

HLS Therapeutics (HLS) Insider Trading & Ownership

HLS Therapeutics logo
C$4.71 0.00 (0.00%)
As of 04:00 PM Eastern

HLS Therapeutics (TSE:HLS) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
0.37%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
C$495.00
Number Of
Insiders Selling
(Last 12 Months)
0
Get HLS Insider Trade Alerts

Want to know when executives and insiders are buying or selling HLS Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

HLS Insider Buying and Selling by Quarter

HLS Therapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/18/2025
Dawn Edinboro
Senior Officer
Buy100C$4.95C$495.00
(Data available from 1/1/2013 forward)

HLS Insider Trading Activity - Frequently Asked Questions

The list of insiders at HLS Therapeutics includes Brian Thomas Walsh, Craig Millian, Dawn Edinboro, John Gordon Hanna, John Lee Welborn Jr., Norma Beauchamp, Polar Asset Management Partners Inc., and Tim Hendrickson. Learn more on insiders at HLS.

0.37% of HLS Therapeutics stock is owned by insiders. Learn more on HLS's insider holdings.

The following insiders have purchased HLS shares in the last 24 months: Craig Millian (C$7,250.00), Dawn Edinboro (C$495.00), John Gordon Hanna (C$3,828.00), John Lee Welborn Jr. (C$6,825.00), and Norma Beauchamp (C$1,957.00).

Insiders have purchased a total of 6,400 HLS shares in the last 24 months for a total of C$20,355.00 bought.

The following insider sold HLS shares in the last 24 months: Norma Beauchamp (C$1,655.00).

Insiders have sold a total of 500 HLS Therapeutics shares in the last 24 months for a total of C$1,655.00 sold.



This page (TSE:HLS) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners